The global Multiple Myeloma market is poised for substantial growth, with a projected value of USD 47,646 million by the year 2030, according to the latest market analysis by The market, which amounted to USD 21,748.15 million in 2022, is estimated to increase at a Compound Annual Growth Rate (CAGR) of 10.3% between 2023 and 2030. Multiple Myeloma, a type of blood cancer characterized...